Demand for Poultry Pharmaceuticals Market to Witness Rapid Surge During the Period 2020–2027


With increasing number of diseases and infections in domestic poultry, the need for effective and affordable vaccines is growing day by day. To meet this demand the pharmaceutical manufacturing companies are focusing more on the manufacturing of vaccines specifically for viral diseases in poultry. As far as regional impact is concerned, North America seems to be gaining significant traction in the poultry pharmaceuticals market. This is typically due to the fact that there is a wide availability of livestock and the implementation of animal healthcare measures in the region. On the contrary, Asia Pacific is exhibiting a positive outlook due to rising urbanization and disposable income.

Consumption of chicken across the globe has increased significantly over the years. As per the U.S. Department of Agriculture (USDA), in 2018, around 65.2 pounds of chicken per person were available in the U.S. to each. As per the same source, chicken availability per person has more than doubled since 1970. As per the United Nations Food and Agriculture Organization (FAO), in 2018, over 68.79 billion chickens were used in the slaughterhouses, increasing from 58.26 billion in 2011. Such massive consumption of chicken has increased the expenditure on poultry pharmaceuticals and related products. Hence, these factors can stimulate growth of the poultry pharmaceuticals market.

Read More: https://bit.ly/37tmT8c

Comments

Popular posts from this blog

U.S. Meibomian Gland Dysfunction Market is growing rapidly with ThermaMEDx introducing a self-healing, disposable, pre-moistened, sterile cleaning eye-pad for use in treating the symptoms of dry eyes and meibomian gland dysfunction

Boston Sci Launched A New Device For Erectile Dysfunction Devices Market

Bakeable Trays Market Estimated To Develop At Cagr at 4.8% During Estimate Duration 2019-2027